Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 8,964 | 8,615 | 8,189 | 7,103 | 7,399 |
| Cost of Goods | 783 | 1,495 | 627 | 586 | 633 |
| Gross Profit | 8,181 | 7,120 | 7,562 | 6,517 | 6,766 |
| Operating Expenses | 111,775 | 113,432 | 100,261 | 113,380 | 108,296 |
| Operating Income | -102,811 | -105,817 | -92,072 | -106,277 | -100,897 |
| Other Income | 1,103,846 | 9,699 | 10,523 | 10,337 | 9,573 |
| Pre-tax Income | 1,001,035 | -96,118 | -81,549 | -95,940 | -91,324 |
| Income Tax | 53,120 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 947,915 | -96,118 | -81,549 | -95,940 | -91,324 |
| Net Income | $947,915 | $-96,118 | $-81,549 | $-95,940 | $-91,324 |
| EPS Basic Total Ops | 16.65 | -1.69 | -1.45 | -1.71 | -1.64 |
| EPS Basic Continuous Ops | 16.65 | -1.69 | -1.45 | -1.72 | -1.64 |
| EPS Diluted Total Ops | 16.22 | -1.69 | -1.45 | -1.71 | -1.64 |
| EPS Diluted Continuous Ops | 16.22 | -1.69 | -1.45 | -1.72 | -1.64 |
| EPS Diluted Before Non-Recurring Items | 4.20 | -1.69 | -1.45 | -1.72 | -1.64 |
| EBITDA(a) | $-105,200 | $-106,833 | $-93,251 | $-105,267 | $-98,194 |